PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-34.02%
Revenue decline while CRK shows 4.42% growth. Joel Greenblatt would examine competitive position erosion.
-5.43%
Both companies reducing costs. Martin Whitman would check industry efficiency trends.
-49.00%
Gross profit decline while CRK shows 41.07% growth. Joel Greenblatt would examine competitive position.
-22.71%
Margin decline while CRK shows 43.57% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
383.87%
G&A growth above 1.5x CRK's 12.29%. Michael Burry would check for operational inefficiency.
-100.00%
Marketing expense reduction while CRK shows 0.00% growth. Joel Greenblatt would examine competitive risk.
-99.24%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
10.81%
Operating expenses growth while CRK reduces costs. John Neff would investigate differences.
3.16%
Total costs growth while CRK reduces costs. John Neff would investigate differences.
4.48%
Interest expense growth less than half of CRK's 9.35%. David Dodd would verify sustainability.
-11.24%
Both companies reducing D&A. Martin Whitman would check industry patterns.
-70.93%
EBITDA decline while CRK shows 590.23% growth. Joel Greenblatt would examine position.
-56.97%
EBITDA margin decline while CRK shows 309.43% growth. Joel Greenblatt would examine position.
-134.64%
Operating income decline while CRK shows 79.87% growth. Joel Greenblatt would examine position.
-152.50%
Operating margin decline while CRK shows 80.72% growth. Joel Greenblatt would examine position.
65.10%
Other expenses growth while CRK reduces costs. John Neff would investigate differences.
-55.82%
Pre-tax income decline while CRK shows 66.14% growth. Joel Greenblatt would examine position.
-136.16%
Pre-tax margin decline while CRK shows 67.57% growth. Joel Greenblatt would examine position.
125.44%
Tax expense growth above 1.5x CRK's 67.84%. Michael Burry would check for concerning trends.
-438.75%
Net income decline while CRK shows 65.27% growth. Joel Greenblatt would examine position.
-716.52%
Net margin decline while CRK shows 66.74% growth. Joel Greenblatt would examine position.
-446.30%
EPS decline while CRK shows 65.52% growth. Joel Greenblatt would examine position.
-442.59%
Diluted EPS decline while CRK shows 65.52% growth. Joel Greenblatt would examine position.
-0.79%
Share count reduction while CRK shows 0.61% change. Joel Greenblatt would examine strategy.
-0.01%
Diluted share reduction while CRK shows 0.61% change. Joel Greenblatt would examine strategy.